Last update 08 May 2025

Synaptic Pharmaceuticals

Private Company|New Jersey, United States

Overview

Tags

Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
GAT3(solute carrier family 6 member 11)1

Related

2
Drugs associated with Synaptic Pharmaceuticals
SNAP-5114
Target
GAT3
Mechanism
GAT3 blockers
Active Org.
Synaptic Pharmaceuticals
Originator Org.
Lundbeck Research USA, Inc.
Active Indication
Nervous System Diseases
Inactive Indication
Epilepsy
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
SNAP-7941
Target
MCHR1
Mechanism
MCHR1 inhibitors
Active Org.-
Originator Org.
Synaptic Pharmaceuticals
Active Indication-
Inactive Indication
Anorexia [+2]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Synaptic Pharmaceuticals
Login to view more data
0 Patents (Medical) associated with Synaptic Pharmaceuticals
Login to view more data
2
Literatures (Medical) associated with Synaptic Pharmaceuticals
01 Jan 1993NIDA research monograph
The use of cloned human receptors for drug design.
NIDA research monograph
The use of cloned human receptors for drug design.
100 Deals associated with Synaptic Pharmaceuticals
Login to view more data
100 Translational Medicine associated with Synaptic Pharmaceuticals
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Jul 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SNAP-5114
 ( GAT3 )		Nervous System Diseases
More
Preclinical
SNAP-7941
 ( MCHR1 )		Depressive Disorder
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free